Open Text CorpOTEX
Price$22.40Intrinsic value$38.2771% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $5.2B+1.5% YoYTTM through 30 Jun 2026
Net Income $643M+47.5% YoYTTM through 30 Jun 2026
Free Cash Flow $807.5MTTM through 30 Jun 2026

Margins

Current
Gross Margin72.3%
EBITDA Margin29.2%
Operating Margin17.3%
Net Margin12.3%

Returns

16.0%ROE
4.9%ROA
7.3%ROIC

Balance Sheet Health

Debt / Equity1.44x
Current Ratio0.81x
Net Debt$4.8B
Cash & Equivalents$956M

Quality Metrics

Altman Z-Score1.21
Piotroski F-Score8 / 9
FCF Margin15.4%
Earnings-Beat Rate100.0%

Multi-Year Trend

Revenue
'20'21'22'23'24'25'26
FY2026: $5.2B
Diluted EPS$2.58TTM
'20'21'22'23'24'25'26
FY2026: $2.58

Dividend

$0.83Per share, FY20263.59%Yield+0.0%5-yr growth

Capital Allocation

Capex Intensity3.8%

Segment Performance

SegmentRevenueYoYOutlook
Cloud services and subscriptions
Customer support
License
Professional service and other

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.